Veritas Genetics is a global pioneer in disease prevention through accessible genetic information. By removing barriers to genetic screening and whole genome sequencing, Veritas Genetics empowers individuals and doctors to make informed lifestyle decisions that enable disease prevention and longer, healthier lives. Veritas is founded by leaders in genomics from Harvard Medical School and operates globally from its offices in the U.S., Europe and China.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/17/16 | $30,000,000 | Series B |
Jiangsu Simcere Pharmaceutical Lilly Asia Ventures Trustbridge Partners | undisclosed |
